Patents-Review.com
🔗 Permalink
Assignee profile:

COCRYSTAL PHARMA, INC.

City:

Bothell, Washington

Country:

United States

Published Applications:

11

Last publication date:

2024-01-18

Patent Grants:

10

Last grant date:

2024-07-16

Top Inventors for applications by COCRYSTAL PHARMA, INC.

These are the the leading inventors for applications assigned to COCRYSTAL PHARMA, INC.:

Recent patent applications by COCRYSTAL PHARMA, INC.

COCRYSTAL PHARMA, INC. based in Bothell, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-01-18
US20240018145A1
Chemistry; metallurgy

POLYCYCLIC CAP-DEPENDENT ENDONUCLEASE INHIBITORS FOR TREATING OR PREVENTING INFLUENZA

 #2 | 2022-02-24 ✅ Patent 12,037,333 granted on 2024-07-16
US20220056024A1
Chemistry; metallurgy

Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication

 #3 | 2022-02-17 ✅ Patent 12,565,488 granted on 2026-03-03
US20220048897A1
Chemistry; metallurgy

INHIBITORS OF INFLUENZA VIRUS REPLICATION

 #4 | 2021-12-23 ✅ Patent 12,156,876 granted on 2024-12-03
US20210393629A1
Human necessities

Formulations of influenza therapeutics

 #5 | 2021-11-18 ✅ Patent 12,233,066 granted on 2025-02-25
US20210353629A1
Human necessities

Combinations of inhibitors of influenza virus replication

 #6 | 2021-06-03 ✅ Patent 11,752,166 granted on 2023-09-12
US20210161935A1
Human necessities

Combination therapy for treatment of HCV

 #7 | 2021-04-29 ✅ Patent 12,357,631 granted on 2025-07-15
US20210121462A1
Human necessities

PYRROLO[2,3-B]PYRIDIN DERIVATIVES AS INHIBITORS OF INFLUENZA VIRUS REPLICATION

 #8 | 2020-08-13 ✅ Patent 10,947,210 granted on 2021-03-16
US20200255393A1
Chemistry; metallurgy

Inhibitors of Hepatitis C virus polymerase

 #9 | 2020-04-23 ✅ Patent 11,014,941 granted on 2021-05-25
US20200123177A1
Chemistry; metallurgy

Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication

 #10 | 2018-02-22 ✅ Patent 10,464,914 granted on 2019-11-05
US20180050998A1
Chemistry; metallurgy

Inhibitors of hepatitis C virus polymerase

 #11 | 2017-09-28 ✅ Patent 10,426,762 granted on 2019-10-01
US20170273962A1
Human necessities

Inhibitors of hepatitis C virus polymerase

Also check out COCRYSTAL PHARMA, INC.'s (Bothell, United States) applicant profile with 11 patent applications submitted.

AssigneeID:

346227 ⎘